Earnings Releases·Nov 4, 2026, 4:06 PM ET

Clover Health — Third Quarter 2026 Earnings Summary

Q3 2026 GAAP Net Income turned profitable at $6.4 million (vs. $24.4M loss YoY), while Total Revenues surged 52.9% YoY to $759.3 million and Adjusted EBITDA jumped 666.7% to $16.1 million.
Management raised full-year 2026 guidance across all key metrics, including membership (157k–158k), revenue ($2.97B–$3.00B), and GAAP Net Income ($25M–$35M), confirming expectations for the first full year of GAAP profitability.
Year-to-date results show strong momentum with $61.8M GAAP Net Income and $203.5M net cash from operating activities, supported by a 240 basis point improvement in Q3 Insurance Benefits Expense Ratio to 91.1%.
Strategic outlook highlights a 5-Star rating for the flagship PPO plan, nation-leading HEDIS performance, and anticipated earnings expansion in 2027 driven by maturing cohorts and operating leverage.